These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6754178)

  • 1. Vascular lesions and angiotensin in malignant hypertension in the absence of vasopressin.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    Clin Exp Pharmacol Physiol; 1982; 9(3):297-301. PubMed ID: 6754178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Malignant hypertension in Brattleboro (vasopressin-deficient) rats.
    Woods RL; Abrahams JM; Kincaid-Smith P; Johnston CI
    J Hypertens; 1983 Jun; 1(1):37-43. PubMed ID: 6397512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of endotoxaemia on pressor and vasoconstrictor actions of angiotensin II and arginine vasopressin in conscious rats.
    Tarpey SB; Bennett T; Randall MD; Gardiner SM
    Br J Pharmacol; 1998 Apr; 123(7):1367-74. PubMed ID: 9579732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of neurohormonal changes following the production of the benign and malignant phases of two-kidney, two-clip Goldblatt hypertension.
    Suzuki H; Saruta T; Ferrario CM; Brosnihan KB
    Jpn Heart J; 1987 May; 28(3):413-26. PubMed ID: 2887673
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between neural mechanisms, the renin-angiotensin system and vasopressin in the maintenance of blood pressure during water deprivation: studies in Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T
    Clin Sci (Lond); 1985 Jun; 68(6):647-57. PubMed ID: 2485266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The contribution of vasopressin and angiotensin to the maintenance of blood pressure after autonomic blockade.
    Hiwatari M; Nolan PL; Johnston CI
    Hypertension; 1985; 7(4):547-53. PubMed ID: 2989171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiovascular and dipsogenic effects of angiotensin II administered i.c.v. in Long-Evans and Brattleboro rats.
    Harland D; Gardiner SM; Bennett T
    Brain Res; 1988 Jul; 455(1):58-64. PubMed ID: 3416193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute arterial fibrinoid deposition and ischaemic parenchymal damage of the kidney. Pathogenic factors in the development of malignant hypertension.
    Chatelain RE; Dardik BN; Shainoff JR
    J Pathol; 1983 Oct; 141(2):125-42. PubMed ID: 6363644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertensive response to acute aortic coarctation in chronic vasopressin deficient states.
    Fregoneze JB; Salgado MC; Castro e Silva EJ; Salgado HC
    Clin Exp Hypertens; 1995 Aug; 17(6):977-88. PubMed ID: 7581264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of vasopressin replacement on renin hypersecretion in Brattleboro rats.
    Golin RM; Gotoh E; Keil LC; Shackelford RL; Ganong WF
    Am J Physiol; 1989 Nov; 257(5 Pt 2):R1117-22. PubMed ID: 2686467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High arterial pressure versus humoral factors in the pathogenesis of the vascular lesions of malignant hypertension.
    Beilin LJ; Goldby FS; Mohring J
    Clin Sci Mol Med; 1977 Feb; 52(2):111-7. PubMed ID: 844244
    [No Abstract]   [Full Text] [Related]  

  • 12. Renin-angiotensin system in stroke-prone spontaneously hypertensive rats.
    Shibota M; Nagaoka A; Shino A; Fujita T
    Am J Physiol; 1979 Mar; 236(3):H409-16. PubMed ID: 426075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pressor contributions from angiotensin and vasopressin after polyethylene glycol.
    Gardiner SM; Bennett T
    Am J Physiol; 1986 Oct; 251(4 Pt 2):R769-74. PubMed ID: 3532827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of arginine-vasopressin for the development of hypertension following aortic constriction.
    Aperia A; Sahlgren B; Eklöf AC; Lundin S; Melin P
    Acta Physiol Scand; 1986 Dec; 128(4):495-9. PubMed ID: 3811978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin and malignant deoxycorticosterone hypertension in rats.
    Möhring J; Möhring B; Petri M; Haack D
    Clin Sci Mol Med Suppl; 1976 Dec; 3():45s-48s. PubMed ID: 1071663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular interactions between vasopressin, angiotensin and noradrenaline in the Brattleboro rat.
    Laycock JF; Lightman SL
    Br J Pharmacol; 1989 Feb; 96(2):347-55. PubMed ID: 2493961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats?
    Möhring J; Möhring B; Petri M; Haack D
    Lancet; 1976 Jan; 1(7952):170-3. PubMed ID: 54684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of vasopressin in hypertension: studies using the Brattleboro rat.
    Woods RL; Johnston CI
    Am J Physiol; 1982 Jun; 242(6):F727-32. PubMed ID: 7091324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of vasopressin to the maintenance of blood pressure during dehydration.
    Woods RL; Johnston CI
    Am J Physiol; 1983 Nov; 245(5 Pt 1):F615-21. PubMed ID: 6356937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats.
    Gardiner SM; Bennett T; Compton AM
    J Auton Nerv Syst; 1988 Sep; 24(1-2):15-27. PubMed ID: 3062060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.